Yimin Cui
Impact in
- Biological Psychiatry top 5%
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 18
- Atrial Fibrillation Management and Outcomes 15
- Surgery 38
- Lipoproteins and Cardiovascular Health 13
- Co-authors
- Qian Xiang (91 shared papers)Ying Zhou (48 shared papers)Xia Zhao (48 shared papers)Xiaocong Pang (10 shared papers)Hanxu Zhang (26 shared papers)Yanlun Gu (11 shared papers)He Xu (8 shared papers)Zhiwei Qiu (5 shared papers)
- Journals
- Frontiers in Pharmacology (9 papers)Clinical Therapeutics (8 papers)British Journal of Clinical Pharmacology (7 papers)Frontiers in Immunology (5 papers)Pharmacogenomics (5 papers)
- Partner nations
- ChinaUnited StatesEstonia
In The Last Decade
Yimin Cui
255 papers receiving 4.8k citations
Yimin Cui's Hit Papers
Peers
Comparison fields: 5 of 161
- Biological Psychiatry 97
- Geriatrics and Gerontology 113
- Internal Medicine 100
- Immunology and Allergy 151
- Cancer Research 350
Countries citing papers authored by Yimin Cui
This map shows the geographic impact of Yimin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Cui more than expected).
Fields of papers citing papers by Yimin Cui
This network shows the impact of papers produced by Yimin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Cui. The network helps show where Yimin Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Yimin Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 271 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting integrin pathways: mechanisms and advances in therapy Hit paper breakdown → | 2023 | 692 |
| 2 | 2019 | 148 | |
| 3 | 2006 | 140 | |
| 4 | 2006 | 105 | |
| 5 | Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis Hit paper breakdown → | 2024 | 98 |
| 6 | 2019 | 90 | |
| 7 | 2004 | 83 | |
| 8 | 2017 | 81 | |
| 9 | 2005 | 75 | |
| 10 | 2013 | 72 | |
| 11 | 2020 | 71 | |
| 12 | 2009 | 64 | |
| 13 | 2019 | 59 | |
| 14 | 2012 | 59 | |
| 15 | 2021 | 56 | |
| 16 | 2015 | 49 | |
| 17 | 2020 | 49 | |
| 18 | 2023 | 47 | |
| 19 | 2020 | 46 | |
| 20 | 2005 | 45 |
About Yimin Cui
Yimin Cui is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Oncology, Molecular Biology and Cancer Research, having authored 271 papers that have together received 4.8k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Atrial Fibrillation Management and Outcomes (15 papers), Lipoproteins and Cardiovascular Health (13 papers), Folate and B Vitamins Research (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Pharmacogenetics and Drug Metabolism (10 papers), Tryptophan and brain disorders (9 papers) and Schizophrenia research and treatment (8 papers). The work is most often cited by research in Biological Psychiatry (97 citations), Geriatrics and Gerontology (113 citations), Internal Medicine (100 citations), Immunology and Allergy (151 citations) and Cancer Research (350 citations). Yimin Cui has collaborated with scholars based in China, United States and Estonia. Frequent co-authors include Qian Xiang, Ying Zhou, Xia Zhao, Xiaocong Pang, Hanxu Zhang, Yanlun Gu, He Xu, Zhiwei Qiu, Ran Xie and Nan Zhao. Their work appears in journals such as Frontiers in Pharmacology, Clinical Therapeutics, British Journal of Clinical Pharmacology, Frontiers in Immunology and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.